Skip to main content
GC Genome Corporation logo

GC Genome Corporation — Investor Relations & Filings

Ticker · 340450 ISIN · KR7340450006 KO Human health and social work activities
Open in API
Filings indexed 30 across all filing types
Latest filing 2026-03-24 Declaration of Voting R…
Country KR South Korea
Listing KO 340450

About GC Genome Corporation

https://gc-genome.com/

GC Genome Corporation is a clinical diagnostics company specializing in genomic analysis to provide personalized healthcare solutions. The company offers a comprehensive suite of genetic diagnosis services across four primary areas: Precision Oncology, Pre & Neonatal Health, Rare Diseases, and Health Checkups. Its key technologies include AI-powered liquid biopsy platforms for early cancer detection, non-invasive prenatal testing (NIPT), and various hereditary cancer panels. Operating a CAP-accredited laboratory, GC Genome focuses on research and development to deliver accurate genetic insights that inform clinical decisions and suggest personalized treatments, aiming to improve patient health outcomes.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is the official results of a company’s regular annual shareholder meeting (정기주주총회결과) held on 2026-03-24, detailing agenda items, voting outcomes (approval status, voting percentages), and director election details. This matches the definition for “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-03-24 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive financial report titled '감사보고서' (Audit Report) for the company '주식회사 지씨지놈' (GC Genome). It includes an independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements for the fiscal year ending December 31, 2025. While it contains an audit report, the document is a full set of audited financial statements, which is the primary component of an Annual Report (10-K equivalent in this context). FY 2025
2026-03-16 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from a Korean company (GC Genome) titled 'Audit Report Submission' (감사보고서 제출). It provides the key financial highlights, audit opinion, and financial statements summary as required by the Korea Exchange (KRX). While it contains financial data, it is a standardized regulatory disclosure form announcing the receipt and submission of the audit report, rather than the full annual report document itself. Therefore, it falls under the category of Audit Report / Information. FY 2025
2026-03-16 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for GC Genome. It contains the agenda for the upcoming annual general meeting, including reports on financial statements, board appointments, and governance matters. While it includes financial statements (balance sheet, income statement, etc.) as attachments for shareholder review, the primary purpose of the document is to formally notify shareholders of the meeting and provide the necessary information for them to vote. According to the filing definitions, this falls under 'Proxy Solicitation & Information Statement' (PSI) as it provides information and requests votes for the meeting.
2026-03-09 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 1% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (a Non-Deal Roadshow). It provides details such as the date, location, purpose, and participants. Since it is an announcement of an event rather than the presentation materials themselves, and it is under 5,000 characters, it falls under the category of a regulatory filing announcement regarding corporate events.
2026-02-23 Korean
주주총회소집결의 (정기주주총회)
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의), which includes the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits). This type of document is a standard proxy solicitation or notice of meeting material sent to shareholders to inform them of upcoming voting items, which falls under the Proxy Solicitation & Information Statement category.
2026-02-06 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.